Seres Therapeutics MCRB
Seres Therapeutics: reports quarterly results
- Form
- 8-K
- Filed
- Period
- Importance
- Major
- Accession
- 0001193125-21-325227
- Document
- 8-K
- Exhibit 99.1
- Press release
- Reports quarterly results (2.02)
Not explained yet; the original is on EDGAR.
Similar companies
Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.
- Oncolytics Biotech ONCY public float $72M, Jun 30, 2025
- Gyre Therapeutics GYRE public float $73M, Jun 30, 2025
- Volitionrx VNRX public float $73M, Jun 30, 2025
- Macrogenics MGNX public float $74M, Jun 30, 2025
- Inovio Pharmaceuticals INO public float $74M, Jun 30, 2025